11.beta.-phenyl-4,9,15-estratrienes, their manufacture and
pharmaceutical preparations containing same
    1.
    发明授权
    11.beta.-phenyl-4,9,15-estratrienes, their manufacture and pharmaceutical preparations containing same 失效
    11(BETA)-PHENYL-4,9,15-ESTRATRIENES,其制造和含有其的药物制剂

    公开(公告)号:US5132299A

    公开(公告)日:1992-07-21

    申请号:US458668

    申请日:1990-01-16

    摘要: New 11.beta. phenyl-4,9,15-estratrienes of formula I ##STR1## are described, where X implies an oxygen atom or a hydroxyimino grouping N.about.OH,R.sup.1 stands for a hydrogen atom or a methyl group,R.sup.2 implies a hydrogen atom, an alkyl radical or an acyl radical with in each case 1 to 10 carbon atoms,R.sup.3 stands for a hydrogen atom, a cyanomethyl group, --(CH.sub.2).sub.n CH.sub.2 Z where n implies the numbers 0, 1, 2, 3, 4 or 5, Z=--H or --OR.sup.5 with R.sup.5 having the significance of a hydrogen atom or an alkyl or acyl group with in each case 1 to 10 carbon atoms, or for --(CH.sub.2).sub.m --C.tbd.C--Y where m=0-2 and Y implies a hydrogen, chlorine, fluorine, iodine or bromine atom, an alkyl, hydroxyalkyl, alkoxyalkyl or acyloxyalkyl group with in each case 1 to 10 carbon atoms,R.sup.4 represents a straight-chain or branched-chain, saturated or unsaturated hydrocarbon radical with up to 8 carbon atoms which contains the grouping ##STR2## with X having the above significance. The compounds have antigestagenic and antiglucocorticoid activity.

    摘要翻译: PCT No.PCT / DE88 / 00447 Sec。 371日期1990年1月16日 102(e)日期1990年1月16日PCT提交1988年7月15日PCT公布。 出版物WO89 / 00578 日本1月26日,1989年。新的11β型苯基-4,9,15-雌三醇,其中X表示氧原子或羟基亚氨基,N代表OH,R1代表氢 原子或甲基,R2表示氢原子,烷基或酰基,在每种情况下为1-10个碳原子,R3表示氢原子,氰基甲基, - (CH2)nCH2Z其中n表示数字 0,1,2,3,4或5,Z = -H或-OR 5,其中R 5具有氢原子或烷基或酰基的含义,在每种情况下为1-10个碳原子,或 - (CH 2) mC 3BOND CY,其中m = 0-2,Y表示氢,氯,氟,碘或溴原子,烷基,羟基烷基,烷氧基烷基或酰氧基烷基,在每种情况下为1-10个碳原子,R4表示直链或 含有至多8个碳原子的支链,饱和或不饱和烃基,其含有具有上述意义的X的分组。 这些化合物具有抗前列腺素和抗糖皮质激素活性。

    Estrogenic 17.alpha.-halogen-vinylestranes
    5.
    发明授权
    Estrogenic 17.alpha.-halogen-vinylestranes 失效
    雌激素17α-卤素 - 乙烯基甲苯

    公开(公告)号:US4725426A

    公开(公告)日:1988-02-16

    申请号:US758982

    申请日:1985-07-25

    摘要: 17.alpha.-bromo-.alpha. and 17.alpha.-iodo-vinyl-estrane derivatives of general formula I ##STR1## wherein X is a bromine or iodine atom in Z or E position,R.sup.1 is hydrogen, hydroxy or acyloxy with up to 3 C atoms,R.sup.2 is hydrogen, alkyl with up to 3 C atoms and alkanoyl and aroyl with up to 7 C atoms,R.sup.3 is hydrogen or methyl,R.sup.4 is a hydrogen atom in the .alpha. or .beta. position,R.sup.5 is hydrogen, methyl or methoxy andR.sup.6 is hydrogen or methyl,are pharmacologically effective with a profile of action like ethinylestradiol and in the form of their radioactively labeled compounds are also valuable diagnostic media.The Z-isomers can be prepared by a new process by reaction of the corresponding 17.alpha.-ethinyl steroids with trialkyl (or phenyl) tin hydride with addition of a free radical former.

    摘要翻译: 17α-α-α-和17α-碘代乙烯基 - 雌酮衍生物,其通式I(I)其中X是Z或E位上的溴或碘原子,R 1是氢,羟基或酰氧基,直到 3个C原子,R2是氢,具有高达3 C原子的烷基和具有多达7个C原子的烷酰基和芳酰基,R3是氢或甲基,R4是α或β位的氢原子,R5是氢,甲基或 甲氧基和R6是氢或甲基,在药理学上有效,其作用如炔雌醇,其放射性标记的化合物的形式也是有价值的诊断介质。 Z-异构体可以通过相应的17α-乙烯基类固醇与三烷基(或苯基)锡氢化物反应并通过加入自由基前体而通过新方法制备。